Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Inogen Inc

INGN
Current price
6.82 USD -0.02 USD (-0.29%)
Last closed 7.09 USD
ISIN US45780L1044
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 190 361 376 USD
Yield for 12 month -3.81 %
1Y
3Y
5Y
10Y
15Y
INGN
21.11.2021 - 28.11.2021

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Address: 859 Ward Drive, Goleta, CA, United States, 93111

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.00 USD

P/E ratio

Dividend Yield

Current Year

+335 705 000 USD

Last Year

+315 660 000 USD

Current Quarter

+80 081 000 USD

Last Quarter

+88 834 000 USD

Current Year

+154 741 000 USD

Last Year

+126 699 000 USD

Current Quarter

+36 289 000 USD

Last Quarter

+41 344 000 USD

Key Figures INGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 728 000 USD
Operating Margin TTM -12.76 %
Price to Earnings
Return On Assets TTM -7.78 %
PEG Ratio 3.48
Return On Equity TTM -18.96 %
Wall Street Target Price 10.00 USD
Revenue TTM 335 704 992 USD
Book Value 7.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 5.50 %
Dividend Yield
Gross Profit TTM 154 740 992 USD
Earnings per share -1.52 USD
Diluted Eps TTM -1.52 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 87.30 %
Profit Margin -10.69 %

Dividend Analytics INGN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History INGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation INGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.28
Price Sales TTM 0.57
Enterprise Value EBITDA -17.60
Price Book MRQ 1.09

Financials INGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INGN

For 52 weeks

6.40 USD 13.33 USD
50 Day MA 8.64 USD
Shares Short Prior Month 790 036
200 Day MA 9.62 USD
Short Ratio 1.90
Shares Short 662 853
Short Percent 2.99 %